X4 Pharmaceuticals, Inc.
XFOR
$4.10
$0.030.74%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 253.00M | 122.19M | 62.95M | 86.95M | 102.06M |
| Total Receivables | 573.00K | 1.61M | 1.87M | 1.17M | 1.71M |
| Inventory | 4.48M | 4.08M | 3.17M | 3.09M | 2.82M |
| Prepaid Expenses | 2.52M | 4.70M | 4.96M | 4.48M | 5.59M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.00M | 224.00K | -- | -- | -- |
| Total Current Assets | 261.58M | 132.81M | 72.94M | 95.70M | 112.18M |
|
|
|||||
| Total Current Assets | 261.58M | 132.81M | 72.94M | 95.70M | 112.18M |
| Net Property, Plant & Equipment | 1.59M | 1.99M | 2.90M | 4.14M | 4.84M |
| Long-term Investments | 17.35M | 17.35M | 17.35M | 17.35M | 17.35M |
| Goodwill | 17.35M | 17.35M | 17.35M | 17.35M | 17.35M |
| Total Other Intangibles | 9.25M | 9.44M | 9.63M | 9.81M | 10.00M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 692.00K | 1.97M | 2.35M | 3.01M | 2.08M |
| Total Assets | 290.46M | 163.56M | 105.17M | 130.01M | 146.45M |
|
|
|||||
| Total Accounts Payable | 5.70M | 5.05M | 7.71M | 11.12M | 8.62M |
| Total Accrued Expenses | 18.60M | 16.44M | 13.07M | 12.61M | 23.01M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 994.00K | 1.20M | 1.37M | 1.30M | 1.25M |
| Total Finance Division Other Current Liabilities | 464.00K | 814.00K | 754.00K | 855.00K | -- |
| Total Other Current Liabilities | 464.00K | 814.00K | 754.00K | 855.00K | -- |
| Total Current Liabilities | 25.76M | 23.51M | 22.90M | 25.88M | 32.88M |
|
|
|||||
| Total Current Liabilities | 25.76M | 23.51M | 22.90M | 25.88M | 32.88M |
| Long-Term Debt | 76.29M | 76.06M | 75.84M | 75.63M | 75.43M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 95.00K | 815.00K | 1.11M | 1.41M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.12M | 2.27M | 1.65M | 4.45M | 14.59M |
| Total Liabilities | 104.17M | 101.94M | 101.20M | 107.07M | 124.30M |
|
|
|||||
| Common Stock & APIC | 780.95M | 632.37M | 544.92M | 538.15M | 537.63M |
| Retained Earnings | -594.55M | -570.63M | -540.81M | -515.07M | -515.36M |
| Treasury Stock & Other | -109.00K | -118.00K | -138.00K | -128.00K | -122.00K |
| Total Common Equity | 186.29M | 61.62M | 3.97M | 22.94M | 22.15M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 186.29M | 61.62M | 3.97M | 22.94M | 22.15M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 186.29M | 61.62M | 3.97M | 22.94M | 22.15M |
|
|
|||||